Hims & Hers Health Stock Jumps Nearly 28% on Plans to Offer GLP-1 Weight-Loss Drugs

Shares of telehealth company Hims & Hers Health soared Monday after the company announced plans to offer GLP-1 injections to treat obesity and diabetes with the same key ingredient as popular weight-loss drugs Ozempic and Mounjaro.

Related Keywords

Denmark ,Danish ,Eli Lilly ,Andrew Dudum ,Hims Hers Health ,Novo Nordisk ,Hers Health ,Weight Loss Drugmaker Stock Prices Boosted ,Surging Demand ,